Tag: COVID-19 Drug
Tech Mahindra may begin trials for planned Covid-19 drug in 3-4...
Tech Mahindra expects to start trials for a Covid drug in the next three to four months after receiving the patent for a particular...
Monday, June 9, 2025
EDITOR PICKS
ABOUT US
SightsIn Plus is a monthly HR Magazine. It is focused on young leaders: their challenges, perspectives and observations, the changes being brought about by them, as they stand witness to the dawn of various disruptions impacting the corporate sector.
Contact us: info@sightsinplus.com
Copyright © 2023 SightsInPlus.com